|
|
|
Volumn 16, Issue 6 Suppl 6, 2002, Pages 63-72
|
|
Docetaxel in the integrated management of prostate cancer. Current applications and future promise.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CLINICAL TRIAL;
FORECASTING;
HUMAN;
MALE;
MORTALITY;
PROSTATE TUMOR;
RECURRENT DISEASE;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
FORECASTING;
HUMANS;
MALE;
NEOADJUVANT THERAPY;
PACLITAXEL;
PROSTATIC NEOPLASMS;
RECURRENCE;
TAXOIDS;
|
|
EID: 0036615319
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (28)
|
|
References (34)
|
